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Objective: Repair of isolated aortic arch aneurysms (nontraumatic) by either open (OAR) or endovascular (TEVAR)
methods is associated with need for hypothermic circulatory arrest, complex debranching procedures, or use of marginal
proximal landing zones. This study evaluates outcomes for treatment of this cohort.
Methods: Of 2153 patients undergoing arch repair (1993-2013), 137 (mean age, 60 years) were treated with isolated arch
resection for nontraumatic aneurysms. Treatment was by open (n[ 93), hybrid (n[ 11), or TEVAR (n[ 33) methods,
with the last two approaches reserved for poor OAR candidates. Treatment was predominantly for saccular (n [ 53) or
fusiform (n[ 30) aneurysms or dissection (n[ 15). Rupture was present in 15%. Prior aortic repair was performed in the
ascending (n[ 30), arch (n[ 40), descending (n[ 24), or abdominal (n[ 9) aorta. Propensity score adjustment was
performed for multivariable analysis to account for baseline differences in patient groups as well as treatment selection bias.
Results: Early mortality was seen in nine patients (7%). Morbidity included stroke (n[ 9), paraplegia (n[ 1), and need for
dialysis (n [ 5) or tracheostomy (n [ 10). A composite outcome of death and stroke was independently predicted by
advancingage (P[ .055) andperformanceofahybridprocedure (P[ .012).The15-year survivalwas59%,with latemortality
predictedby increasing age, presence of peripheral vascular disease, andperioperative stroke (allP< .05). The 10-year freedom
from aortic rupture or reintervention was 75% and was higher after OAR (2-year OAR, 94% vs TEVAR or hybrid, 78%;
P[ .018). After propensity-adjusted Cox regression analysis, both prior abdominal aortic aneurysmectomy (P[ .017) and
an endovascular or hybrid procedure (P[ .001) independently predicted late aortic rupture or need for reintervention.
Conclusions: Isolated arch repair remains a high-risk procedure occurring frequently in the reoperative setting. Despite
being performed in a higher risk group, endovascular strategies yielded similar outcomes but with an increased risk for
aorta-related complications. These data support ongoing efforts to develop branched endografts speciﬁcally tailored for
arch disease to potentially reduce morbidity related to currently available approaches. (J Vasc Surg 2014;60:57-63.)Since the ﬁrst reported attempts at arch aneurysm
repair by Michael DeBakey, morbidity rates have improved
dramatically.1-3 Whereas the majority of arch aneurysms
exist as distal extensions of more proximal aortic disease
or proximal extensions of descending aortic disease, the
isolated nontraumatic arch aortic aneurysm represents a
unique entity with its associated challenges. Exposure for
traditional open aortic repair (OAR) of this pathologic pro-
cess is through a median sternotomy or a thoracotomy,
depending on the relative location of the arch to the
midline of the chest. OAR also frequently requires adjunc-
tive use of hypothermic circulatory arrest with its attendant
increased morbidity, particularly if it is performed from a
thoracotomy.4 The associated pathologic process oftenthe Departments of Cardiac Surgerya and Radiology,b University of
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://dx.doi.org/10.1016/j.jvs.2014.01.066either is a saccular aneurysm arising from a penetrating
ulcer with its high associated atherosclerotic burden
(Fig 1) or occurs in the reoperative setting of prior incom-
plete proximal or distal aneurysm resection, both of which
contribute to increased morbidity.
In the last decade, endovascular options have been used
to reduce the morbidity of thoracic aortic repair.5 Thoracic
endovascular aortic repair (TEVAR) has several limitations
when it is extended to the arch aorta. These include the
higher risk of stroke and the presence of inadequate landing
zones due to arch branch vessel proximity or arch curva-
ture.6,7 In an effort to overcome these anatomic constraints,
complex extra-anatomic arch vessel bypasses are con-
structed to extend proximal landing zones. These hybrid
procedures have been evaluated in prior studies and have
also been associated with signiﬁcant morbidity.8-14 How-
ever, these reports have often included large numbers of
patients in whom the arch is modiﬁed to facilitate a repair
of a predominantly descending thoracic aneurysm rather
than solely focusing on an isolated arch aortic aneurysm.
With the advent of these newer approaches, we undertook
this 20-year study to evaluate both early and late outcomes
associated with treatment of isolated arch aortic disease.
METHODS
This study was approved by the Institutional Review
Board of the University of Michigan Hospitals (IRB
HUM00044262; informed consent waived). Data from57
Fig 1. This three-dimensional reconstruction is an example of the
typical saccular aneurysm evaluated in this study and probably
arose from a penetrating ulcer in a 79-year-old ex-smoker who had
associated coronary artery disease. This patient underwent subse-
quent total arch debranching with thoracic endovascular aortic
repair (TEVAR) and concomitant left internal mammary artery
bypass grafting to the left anterior descending coronary artery.
JOURNAL OF VASCULAR SURGERY
58 Sood et al July 2014all patients who underwent operative therapy for nontrau-
matic, isolated aortic arch aneurysms at the University of
Michigan from 1993 to 2013 were retrospectively collected
and analyzed.
Of 2153 patients undergoing arch repair from 1993 to
2013, 137 (mean age, 60 years) were treated with isolated
arch resection for nontraumatic aneurysms. Patients with
ascending aneurysms extending into the arch or descending
aneurysms that began in the arch and extended distally
beyond the level of the left pulmonary artery were excluded.
Indications for treatment were predominantly saccular
aneurysm (n ¼ 53), fusiform aneurysm (n ¼ 30), or type B
dissection (n ¼ 15). Rupture was present in 15% of patients
(n¼ 21), and a prior aortic repair had been performed in the
ascending (n ¼ 30; 22%), arch (n ¼ 40; 29%), descending
(n ¼ 24; 18%), or abdominal (n ¼ 9; 7%) aorta.
Determination of type of aortic repair was at the discre-
tion of a surgeon experienced in aortic reconstruction. In
general, evaluation for TEVAR or hybrid strategies was per-
formed in a multidisciplinary fashion and reserved for poor
OAR candidates who had complex aortic arch aneurysms.
OAR was performed in 93 patients. All open repairs
were performed with extracorporeal perfusion support
(mean perfusion times, 177 6 59 minutes). Left-sided
heart bypass was used in 13 patients. The remaining 80 pa-
tients had adjunctive use of deep hypothermic circulatory
arrest (mean, 47 minutes), as previously described.3,4
For those patients undergoing an endovascular strat-
egy, stent graft sizing and procedural technique wereperformed as previously described.5 Our institutional pref-
erence employed a “bypass all” strategy of left subclavian
artery revascularization unless a patient presented with
frank rupture and hemodynamic instability. Forty-four pa-
tients were treated with an endovascular strategy classiﬁed
according to Ishimaru.15 Treatment into Ishimaru zone 2
(ie, proximal extent of therapy to distal origin of left carotid
artery but not including it) was performed in 33 patients.
Of this group, 25 patients underwent adjunctive left
carotid to left subclavian arterial bypass; eight were treated
without branch vessel revascularization because of marginal
hemodynamic presentation. Finally, 11 patients underwent
a hybrid endovascular procedure with arch vessel debranch-
ing, followed by TEVAR, with extension into zone 0 (treat-
ment to include innominate artery and proximally). One
patient had repair that extended only into zone 1. The
arch vessel debranching usually consisted of initial left ca-
rotid to left subclavian arterial bypass, followed by median
sternotomy and construction of ascending aorta to innom-
inate artery and left carotid artery bypasses with a prefabri-
cated Dacron prosthesis in nine patients. In two patients,
replacement of the ascending aorta was needed to
construct an appropriate proximal landing zone. This
two-stage process was completed in the same hospitaliza-
tion for seven patients and in a more delayed fashion in
two patients. Ten patients had concomitant antegrade stent
graft delivery; the remaining patient underwent delayed
transfemoral delivery. Concomitant procedures included
coronary artery bypass grafting and aortic valve replace-
ment in four patients and in one patient, respectively.
In patients who were treated with an endovascular
strategy, devices included TAG (W. L. Gore, Flagstaff, Ariz
[n ¼ 31]), TX2 (Cook, Bloomington, Ind [n ¼ 12]), and
Relay (Bolton Medical, Sunrise, Fla [n ¼ 1]).
Preoperative lumbar drains were placed in hemodynam-
ically stable patients at the discretion of the surgeon. Drains
were placed in 52 patients (OAR 60% vs TEVAR or hybrid
11%; P < .001). Postoperative prevention of spinal cord
ischemia was undertaken for patients whose aneurysms
were of the distal arch and in whom the extent of treatment
involved a component of the proximal descending aorta. In
these patients, for all modalities of treatment, postoperative
management was conducted as previously described.4,5
Theprimaryoutcomeof this studywas all-cause latemor-
tality. Important additional outcomes included composite
outcomes of death and stroke as well as death and major
morbidity (stroke, spinal cord ischemia, dialysis requirement,
and need for tracheostomy) and, ﬁnally, an evaluation of
treatment efﬁcacy.Datawere collected from clinic visit notes,
hospital charts, and imaging studies, and mortality was veri-
ﬁed by interrogation of the Social Security Death Index.2
Follow-up was 100% complete for the primary outcome as
of September 2013 (mean follow-up, 666 52 months).
Statistical analysis. Data were analyzed with SPSS
software (SPSS, Chicago, Ill). All data are expressed as
mean6 standard deviation where applicable. Dichotomous
variables were evaluated by c2 analysis, continuous vari-
ables by one-way analysis of variance. A propensity score
Table I. Demographics, comorbidities, and procedural
details with univariate analysis of the study cohort
Study cohort characteristics
Open repair
(n ¼ 93)
TEVAR or
hybrid
(n ¼ 44) P value
Demographics
Mean age 6 SD, years 57 6 13 66 6 15 <.001
Male 65 (70) 31 (71) .947
Comorbidities
History of tobacco abuse 78 (84) 5 (11) <.001
Diabetes mellitus 8 (9) 3 (11) .607
Hypertension 72 (77) 33 (75) .755
Prior CVA 7 (8) 6 (14) .255
COPD 17 (18.3) 8 (18.2) .989
Connective tissue disease 8 (9) 2 (5) .386
Prior AAA repair 4 (4) 5 (11) .119
Prior ascending repair 25 (27) 5 (11) .04
Prior arch repair 33 (36) 7 (16) .019
Prior descending repair 19 (20) 5 (11) .192
Other cardiac intervention 12 (13) 5 (11) .799
Prior MI 7 (8) 5 (11) .458
History of CHF 6 (7) 2 (5) .6567
Mean creatinine
concentration6 SD, mg/dL
1.1 6 0.4 1.2 6 1.0 .801
Underlying aortic disease
Saccular aneurysm 28 (30) 25 (57) .003
Fusiform, prior descending 16 (17) 2 (5) .041
Fusiform, prior ascending 1 (1) 0 (0) .49
Anomalous right subclavian 5 (5) 3 (7) .737
Type B dissection 10 (11) 5 (11) .915
Procedural details
Hemodynamic instability on
presentation
1 (1) 2 (5) .195
Emergent or urgent status 22 (24) 15 (34) .199
Aortic rupture 15 (16) 6 (14) .803
Preoperative lumbar drain 47 (60) 5 (11) <.001
AAA, Abdominal aortic aneurysm; CHF, congestive heart failure; COPD,
chronic obstructive pulmonary disease; CVA, cerebrovascular accident; MI,
myocardial infarction; SD, standard deviation.
Data are presented as number (%) unless otherwise indicated.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 1 Sood et al 59for type of treatment was constructed from a binary logistic
regression with age, tobacco use, preoperative creatinine
concentration, prior history of stroke or ascending or arch
repair, presentation with rupture or saccular aneurysm,
and era of procedure as covariates. The era of procedure
was divided into three time periods: 1993-April 2005
(pre-TEVAR commercialization), May 2005-2008 (early
commercial TEVAR experience), and 2009-2013 (late
commercial TEVAR experience). Multivariate models (bi-
nary logistic regression or Cox proportional hazards anal-
ysis) were constructed by a forward conditional process to
identify factors that were independently associated with
each of the outcomes of interest. The factors used in
multivariate analysis included those with P # .05 on uni-
variate analysis. This analysis was then performed again for
each of the outcome variables, with inclusion of
the propensity score as a covariate to account for treatment
selection bias. Survival analysis was analyzed by Kaplan-
Meier methods, with log-rank testing where applicable. All
results with P < .05 were considered statistically signiﬁcant.
RESULTS
The mean age of the cohort was 59 6 14 years (70%
male). Demographic data and comorbidities are listed in
Table I. This comparative analysis identiﬁes the endovascu-
lar strategy group as older, with a higher frequency of
tobacco use and saccular aneurysm aortic disease but less
frequent history of prior ascending or arch repair (all
P < .05). Procedural details are also listed in Table I. Mean
duration of hospitalization was 146 13 days and was signif-
icantly shorter after endovascular repair (mean, 96 7 days vs
OAR, 166 14 days; P< .001). In addition, intubation time
was signiﬁcantly shorter after endovascular repair (mean,
256 36 hours vs OAR, 696 138 hours; P ¼ .005).
Early results. Early mortality (deﬁned as in-hospital or
30-day mortality) was seen in nine patients (7%) and was
not signiﬁcantly different between the treatment groups
(OAR, n ¼ 6 [8%] vs endovascular strategy, n ¼ 3 [7%];
P ¼ .936). After OAR, causes of early mortality included
perioperative stroke (n ¼ 4), intraoperative myocardial
infarction (n ¼ 1), and rupture of the proximal aortic
anastomosis in a patient who presented emergently with a
contained arch rupture (n ¼ 1). Causes of early mortality
after the endovascular strategy included aortic dissection
and rupture after zone 0 debranching and TEVAR for
saccular aneurysm (n ¼ 1); cardiogenic shock from right
coronary artery occlusion after zone 0 arch debranching,
TEVAR, and aortic valve replacement for saccular aneu-
rysm and moderate to severe aortic stenosis (n ¼ 1); and
perioperative stroke after emergent zone 2 TEVAR for
acute type B dissection (n ¼ 1).
Attesting to the morbidity of repair for this disease, the
frequency of neurologic events in this population was high.
Permanent stroke was seen in nine patients (7%) but with
no signiﬁcant difference among the treatment groups
(OAR, n ¼ 7 [8%] vs TEVAR or hybrid, n ¼ 2 [5%];
P ¼ .511). Of the endovascular strategy patients who suf-
fered strokes, both had undergone off-pump coronary arterybypass along with zone 0 debranching and TEVAR. Tran-
sient stroke was seen in three patients, all from the TEVAR
or hybrid group (hybrid, n ¼ 1; TEVAR, n ¼ 2). Impor-
tantly, neither temporary nor permanent stroke was associ-
ated with lack of left subclavian arterial revascularization
(P > .38). Spinal cord ischemia was seen in just one patient
who underwent zone 2 TEVAR and did not undergo preop-
erative lumbar drain placement or left subclavian artery
bypass because of emergent need for intervention. Renal fail-
ure requiring dialysis was identiﬁed in ﬁve patients (4%) and
equally divided between the treatment groups (OAR, n¼ 4
vs TEVAR or hybrid, n ¼ 1; P ¼ .554). Finally, prolonged
ventilation as deﬁned by the need for tracheostomywas iden-
tiﬁed in 10patients, all from theOARgroup (OAR,n¼10vs
TEVAR or hybrid, n ¼ 0; P ¼ .024).
A composite outcome consisting of early mortality and
signiﬁcant morbidity (operative death, 30-day death,
continuous coma, permanent stroke, transient stroke,
need for dialysis, and tracheostomy) was constructed for
multivariable analysis. The composite outcome of these
morbidities was independently predicted by presentation
Fig 2. Kaplan-Meier analysis of the entire cohort (A) reveals that
the 15-year survival is 59% 6 9% (mean 6 standard error). Strat-
iﬁed by treatment approach (B), there is no survival difference at
5 years between the open repair (70% 6 5%) and endovascular
strategy (86% 6 6%) groups (log-rank, P ¼ .57).
Fig 3. Actuarial analysis examining efﬁcacy of treatment suggests
that the 10-year freedom from aortic rupture or need for reinter-
vention (ie, treatment failure) is 75% 6 7% (A, mean 6 standard
error). A comparative analysis (B) shows that at 2 years, the endo-
vascular group has a treatment failure rate of 78%6 10% compared
with 94% 6 3% for the open repair group (log-rank, P ¼ .02).
Cox regression analysis also revealed that endovascular treatment
strategy independently predicted late treatment failure.
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unchanged when treatment type and propensity score
were added as covariates. In construction of a multivariable
model for a composite outcome of early mortality and
stroke, both age (OR, 1.05; P ¼ .055) and performance
of a hybrid procedure alone (OR, 6.36; P ¼ .012) emerged
as important predictors. Again, adjustment with treatment
propensity score did not affect results.
Late results. The crude mortality of the entire cohort
was 22.6% (n ¼ 31). By Kaplan-Meier analysis, the 15-year
survival was estimated at 59.0% (Fig 2, A). Stratiﬁed by
treatment algorithm, 5-year survival was similar (P ¼ .57;
Fig 2, B). Cox regression analysis revealed that important
predictors of late mortality for the entire cohort included
advancing age (hazard ratio [HR], 1.05; P ¼ .003), periph-
eral vascular disease (HR, 2.23; P¼ .035), and perioperative
stroke (HR, 5.65; P < .001) but not treatment strategy
(P ¼ .16), even with adjustment for propensity score.An analysis was also performed evaluating the efﬁcacy
of treatment strategy. On univariate analysis, a history of
hyperlipidemia and prior abdominal aortic aneurysm repair
was associated with an increased risk of aortic rupture or
aortic reintervention (all P < .05). For the entire cohort,
survival analysis suggested that the 10-year freedom from
aortic rupture or reintervention was 75% (Fig 3, A). Strat-
iﬁed by therapeutic strategy, the performance of an endo-
vascular repair was associated with a higher 2-year risk for
treatment failure (P ¼ .018; Fig 3, B). With use of a Cox
regression analysis adjusted for treatment propensity score,
both prior abdominal aortic aneurysm repair (HR, 4.38;
P ¼ .017) and endovascular treatment strategy (HR,
7.67; P ¼ .001) were independent predictors of aortic
Table II. Aortic events, treatments, and outcomes
Original operation Event Time to event Reintervention Outcome
1. Hybrid intervention Pseudoaneurysm formation in the
descending thoracic aorta
30 months Reoperation of adjacent
aorta (TEVAR)
Alive
2. Hybrid intervention Aortic rupture 3 days None Deceased
3. Hybrid intervention Type III junctional endoleak
between two overlapping stents
18 months Reoperation of adjacent
aorta (TEVAR)
Alive
4. OAR Aortobronchial ﬁstula secondary
to infected graft
70 months Reoperation of adjacent
aorta (TEVAR)
Deceased
5. TEVAR Acute type A dissection, involving
the arch
1 month Reoperation of adjacent
aorta (OAR)
Alive
6. TEVAR Type I endoleak 29 months Reoperation of adjacent
aorta (OAR)
Alive
7. OAR New aneurysm formation,
contained rupture in the
distal arch
28 months Reoperation of adjacent
aorta (OAR)
Alive
8. OAR New aneurysm formation of the
root, ascending, and distal
aortic arch
158 months Reoperation of adjacent
aorta (OAR)
Alive
9. OAR Acute type A dissection, involving
the arch
36 months Reoperation of adjacent
aorta (OAR)
Alive
10. OAR Aortobronchial ﬁstula, saccular
aneurysm of the distal arch
81 months Reoperation of adjacent
aorta (TEVAR)
Alive
11. OAR Type B dissection with aneurysm
formation involving the arch
8 months Reoperation of adjacent
aorta (TEVAR)
Alive
12. OAR Aortic rupture 0 days None Deceased
13. OAR New aneurysm formation in the
descending thoracic aorta
61 months Reoperation of adjacent
aorta (TEVAR)
Alive
14. OAR Aortobronchial ﬁstula secondary
to infected graft
18 months Reoperation of adjacent
aorta (TEVAR and OAR)
Alive
15. TEVAR Chronic type B dissection,
enlarging distal arch aneurysm
2 months Reoperation of adjacent
aorta (OAR)
Alive
16. TEVAR New aneurysm formation in the
descending thoracic aorta
38 months Reoperation of adjacent
aorta (TEVAR)
Alive
17. TEVAR Type I and III endoleak 4 months Reoperation of adjacent
aorta (TEVAR)
Alive
18. TEVAR Infected carotid-subclavian graft 1 month Reoperation for carotid-subclavian
graft débridement
Alive
OAR, Open aortic repair; TEVAR, thoracic endovascular aortic repair.
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in the entire cohort.DISCUSSION
Isolated (nontraumatic) aortic arch aneurysms are un-
common conﬁgurations of thoracic aneurysms that present
unique challenges for successful repair. The pathologic pro-
cess associated with this lesion represents one of several
conﬁgurations. A frequently seen morphologic type is a
saccular conﬁguration with its associated penetrating ulcer
and concomitant generalized high atherosclerotic burden
(Fig 1). Isolated arch aneurysms can also occur with a prior
history of ascending or descending aortic repair, in which
the respective inadequately resected adjacent arch segment
has enlarged and requires reoperation. Finally, other
unique pathologic changes, such as aberrant arch vessel
anatomy, can also be manifested with isolated arch disease.
With thoracic aneurysm repair evolving toward a more
endovascular-based strategy, we analyzed outcomes associ-
ated with both open and endovascular repair of isolated
arch aneurysms during 20 years.Our data suggest that the isolated arch aortic repair is
associated with a relatively high risk of perioperative stroke
and death.3 The primary outcome of late mortality was also
affected by the occurrence of perioperative stroke. Finally,
although the risk for late aortic treatment failure was higher
for the endovascular group (HR, 7.67; P ¼ .001), this did
not portend a higher risk for late mortality (P ¼ .97), sug-
gesting that strategies to minimize the occurrence of peri-
operative stroke may improve overall results. It is also
noteworthy that lack of left subclavian artery revasculariza-
tion was not correlated with an increased risk for stroke.
Whereas advancing age and intervention on the arch itself
are expected to have an increased risk for these early deaths
and stroke for both open and endovascular repair, the
unique ﬁnding in this study was that their occurrence was
also independently associated with the performance of a
hybrid arch procedure.
In the absence of commercially available arch branched
grafts, this procedure has been suggested as a potentially
less invasive option for treatment of arch aneurysms by
avoiding the use of extracorporeal perfusion and deep hy-
pothermic circulatory arrest (100% and 86% of our open
JOURNAL OF VASCULAR SURGERY
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uating hybrid arch repair have shown mixed results with
this approach.8-11 In these studies, early mortality and
stroke rates have varied from 0% to 20.8% and 0.8% to
18.8%, respectively, but the procedures described have
often variably included frozen elephant trunk procedures
(which require hypothermic arrest) or extensive descending
aortic repair. Czerny et al,12 in a transcontinental registry
evaluation of 66 zone 0 hybrid arch debranching proce-
dures, observed an early mortality rate of 9% and stroke
rate of 5%. Similarly, Cao et al,13 in a systematic review
of 27 studies describing 642 patients undergoing hybrid
arch debranching, also suggested that the rates of perioper-
ative death and stroke averaged 11.9% and 7.3%. Finally, a
meta-analysis of four studies comparing open total arch
replacement with hybrid arch repair showed no survival
advantage of arch debranching and a trend toward
increased neurologic events (OR, 1.93; P ¼ .1), again
attesting to the morbidity of this approach.14
Although it is unknown whether branched or fenes-
trated arch graft technology may improve early and late
outcomes compared with conventional open repair, early
reports of total endovascular arch repair appear prom-
ising.16,17 In a recent review of the chimney graft tech-
nique to preserve arch vessels during endograft repair in
124 patients, the risks of early stroke and death were 4%
and 4.8%, respectively.16 At a median of 11.4 months,
there was an 18% endoleak rate and a 100% patency rate
for the chimney grafts, suggesting at least midterm efﬁcacy.
Similarly, Yokoi et al,17 evaluating a precurved fenestrated
endograft speciﬁcally designed for the aortic arch in 35 Jap-
anese centers, reported death and stroke rates of less than
2%. These data suggest that a totally endovascular approach
for isolated arch disease even extending to zone 0 not only
is feasible but can be accomplished with excellent early
results, particularly with regard to the risks for stroke and
perioperative mortality. However, our results showing
diminished late treatment efﬁcacy for an endovascular-
based approach should provide caution even with arch-
speciﬁc endografts, and a rigorous assessment of these
devices compared with conventional open surgery should
be considered before broader application.
There are limitations to our study. First, this is a retro-
spective study limited by sampling bias and size. The sec-
ond and most important limitation of this study remains
the baseline patient differences between groups. There is
an obvious selection bias with respect to treatment strategy,
with those generally undergoing TEVAR considered un-
suitable for conventional open repair. We attempted to ac-
count for this with use of multivariable analysis adjusted by
a treatment strategy propensity score derived from multiple
preoperative variables thought to be either clinically impor-
tant in treatment allocation or signiﬁcantly different be-
tween treatment groups as well as time period of the
procedure. Despite this limitation, we believe that this
study provides a unique comparative evaluation in which
the results were similar between treatment strategies for
the primary outcome of late mortality. Given the frequencyof this disease process, a true randomized evaluation would
likely require multiple sites and many years to complete and
will likely not occur.
CONCLUSIONS
Understanding the patient population at hand, we
conclude that repair of an isolated arch aortic aneurysm
can be performed with acceptable early and late results.
Cerebrovascular accidents remain an important predictor
for both early and late mortality. Although the risk for late
rupture or reintervention remains higher, an endovascular
strategy may yield a shorter duration of hospitalization and
similar early and late survival, particularly in the absence of
need for concomitant hybrid arch debranching. These data
support the ongoing efforts to develop branched endografts
speciﬁcally tailored for arch disease to potentially reduce
morbidity related to currently available approaches.AUTHOR CONTRIBUTIONS
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